Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
OTC:ROSGQ
Price:
0.0001 USD
Updated:
Apr 29, 2024
Rosetta Genomics Ltd
Cash from Financing Activities
|
Rosetta Genomics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Cash from Financing Activities
$3.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Financing Activities
$1.1m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Financing Activities
$22.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Financing Activities
$116.9m
|
CAGR 3-Years
92%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Financing Activities
$6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Financing Activities
-₪1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rosetta Genomics Ltd's Cash from Financing Activities?
Cash from Financing Activities
3.3m
USD
3.3m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Cash from Financing Activities amounts to 3.3m USD.
What is Rosetta Genomics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-23%
-23%
Over the last year, the Cash from Financing Activities growth was -81%. The average annual Cash from Financing Activities growth rates for Rosetta Genomics Ltd have been -12% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
